A Family With Paroxysmal Nonkinesigenic Dyskinesia: Genetic and Treatment Issues

Pediatric Neurology

Volumn 41, Issue 2, 2009, Pages 135-138

  Szczałuba, Krzysztof ^a   Jurek, Marta ^a   Szczepanik, Elzbieta ^a   Friedman, Andrzej ^b   Milewski, Michał ^a   Bal, Jerzy ^a   Mazurczak, Tadeusz ^a  

^a INSTITUTE OF MOTHER AND CHILD   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; ETIRACETAM;

ADULT; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DYSKINESIA; FAMILY HISTORY; FAMILY STUDY; FEMALE; GENE; GENE MUTATION; HUMAN; MALE; NEUROLOGIC EXAMINATION; PAROXYSMAL NONKINESIGENIC DYSKINESIA; PAROXYSMAL NONKINESIGENIC DYSKINESIA GENE; PENETRANCE; POLAND; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ADULT; ANTICONVULSANTS; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHOREA; DIAZEPAM; DNA MUTATIONAL ANALYSIS; FAMILY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUTATION; PEDIGREE; PENETRANCE; PHENOTYPE; PIRACETAM;

EID: 67649605050     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2009.02.013     Document Type: Article

References (14)

1. Bhidayasiri R., and Pulst S.M. Dystonia (DYT) genetic loci. Eur J Pediatr Neurol 9 (2005) 367-370
2. Bruno M.K., Lee H.Y., Auburger G.W., et al. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology 68 (2007) 1782-1789
3. Stefanova E., Djarmati A., Momcilović D., et al. Clinical characteristics of paroxysmal nonkinesigenic dyskinesia in Serbian family with myofibrillogenesis regulator 1 gene mutation. Mov Disord 21 (2006) 2010-2015
4. Rainier S., Thomas D., Tokarz D., et al. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch Neurol 61 (2004) 1025-1029
5. Friedman A., Zakrzewska-Pniewska B., Domitrz I., Lee H.Y., Ptacek L., and Kwiecinski H. Paroxysmal non-kinesigenic dyskinesia caused by the mutation of MR-1 in a large Polish kindred. Eur Neurol 61 (2009) 39-41
6. Lee H.Y., Xu Y., Huang Y., et al. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet 13 (2004) 3161-3170
7. Li T.B., Liu X.H., Feng S., et al. Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle. Acta Biochim Biophys Sin (Shanghai) 36 (2004) 412-418
8. Alemdar M., Iseri P., Selekler M., and Komsuoǧlu S.S. Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia. Clin Neuropharmacol 30 (2007) 241-244
9. Surges R., Volynski K.E., and Walker M.C. Is levetiracetam different from other antiepileptic drugs?. Levetiracetam and its cellular mechanism of action in epilepsy revisited [Erratum at. http://tan.sagepub.com/content/vol1/issue1/
10. Surges R., Volynski K.E., and Walker M.C. Is levetiracetam different from other antiepileptic drugs?. Levetiracetam and its cellular mechanism of action in epilepsy revisited [Erratum at. Ther Adv Neurol Disord 1 (2008) 13-24
11. 2+ transients and epileptiform potentials In hippocampal neurons. Neuroreport 14 (2003) 471-475
12. sz mutant hamster. Eur J Pharmacol 601 (2008) 99-102
13. Lynch B.A., Lambeng N., Nocka K., et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 101 (2004) 9861-9866
14. Dooley J.M., and Brna P.M. Sublingual lorazepam in the treatment of familial paroxysmal nonkinesigenic dyskinesia. Pediatr Neurol 30 (2004) 365-366